The Humoral Immune Response Against the gB Vaccine: Lessons Learnt from Protection in Solid Organ Transplantation

Human cytomegalovirus (hCMV) is considered to be the highest priority for vaccine development. This view is underscored by the significant morbidity associated with congenital hCMV infection and viraemia in transplant patients. Although a number of vaccines have been trialed, none have been licensed...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Ariane C., Griffiths, Paul D., Reeves, Matthew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789498/
https://www.ncbi.nlm.nih.gov/pubmed/31319553
http://dx.doi.org/10.3390/vaccines7030067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789498/
https://www.ncbi.nlm.nih.gov/pubmed/31319553
http://dx.doi.org/10.3390/vaccines7030067

Ejemplares similares